109137 ⎘
Structure or type of the nucleic acid; Type of nucleic acid catalytic nucleic acids, e.g. ribozymes Hairpin
Treatment using truncated Trk B and Trk C antagonists
#302Methods used to treat cancer
#303REDUCTION OF TRAF1 LEVELS COMBINED WITH NUTRIENT STRESS FOR TREATING LYMPHOCYTE-RELATED CANCERS
#304Modulators of intracellular chloride concentration for treating down syndrome
#305Multi-arm biodegradable polymers for nucleic acid delivery
#306Methods for treating hepatitis C virus infectious disease
#307Compositions and methods for promoting the mineralization of biological tissue
#308METHODS OF CONTROLLING VASCULARITY USING RAVER2 AS A MEDIATOR FOR EXPRESSION OF VEGF RECEPTOR SFIT1
#309Reactivation of Axon Growth and Recovery in Chronic Spinal Cord Injury
#310Short hairpin RNA compositions, methods of making and applications thereof
#311Methods for predicting the progression and treating a chronic kidney disease in a patient
#312ATRX AS A COMPANION DIAGNOSTIC FOR CDK4 INHIBITORS
#313Composition for treatment or metastasis suppression of cancers which includes p34 expression inhibitor or activity inhibitor as active ingredient
#314COMPOSITIONS AND METHODS FOR ENHANCED SENSITIVITY AND SPECIFICITY OF NUCLEIC ACID SYNTHESIS
#315SAB as a Biomarker for Degenerative Diseases and Therapeutic Sensitivity in Cancers
#316Therapeutic and diagnostic methods relating to cancer stem cells
#317TOX INHIBITION FOR THE TREATMENT OF CANCER
#318RNA Modification to Engineer Cas9 Activity
#319Composition for treating cancer associated with HPV infection
#320Predicting and treating diabetic complications
#321Spalt-like transcription factor 4 (SALL4) and uses thereof
#322COMBINATION THERAPY WITH C-MET AND EGFR ANTAGONISTS
#323Method of enhancing the efficacy of anti-hepatocyte growth factor receptor breast cancer therapy by administering an inhibitor of mena
#324THERAPEUTIC AND DIAGNOSTIC METHODS RELATING TO CANCER STEM CELLS
#325COMPOSITIONS AND METHODS FOR ENHANCED SENSITIVITY AND SPECIFICITY OF NUCLEIC ACID SYNTHESIS
#326Reactivation of axon growth and recovery in chronic spinal cord injury
#327Eukaryotic layered vector initiation systems
#328Compositions and methods for temperature-dependent nucleic acid synthesis
#329COMBINATION THERAPY WITH C-MET AND EGFR ANTAGONISTS
#3302' Deoxy-2'-Alkylnucleotide Containing Nucleic Acid
#331Nucleic Acid-Mediated Treatment of Diseases or Conditions Related to Levels of Vascular Endothelial Growth Factor Receptor (VEGF-R)
#332Circular DNA vectors for synthesis of RNA and DNA
#333COMPOSITIONS AND METHODS FOR ENHANCED SENSITIVITY AND SPECIFICITY OF NUCLEIC ACID SYNTHESIS
#334Method for Producing Non-Pathogenic Helper Virus-Free Preparations of Herpes Virus Amplicon Vectors, the Helper Virus and the Cells Used in this Method, the Corresponding Generic Tools, as Well as the Applications of These Non-Pathogenic Amplicon Vectors
#335Polynucleotides capable of target-depedent circularization and topological linkage
#336Enzymatic nucleic acid-mediated treatment of ocular diseases or conditions related to levels of vascular endothelial growth factor receptor (VEGF-R)
#337Inhibition of hair growth with RNAi targeting desmoglein 4 and nude mRNAs
#338Protein Arginine N-Methyltransferase 2 (PRMT-2)
#339Synthesis, deprotection, analysis & purification of RNA & ribozymes
#340Ribozyme therapy for the treatment of proliferative skin and eye diseases
#3412'-deoxy-2'alkylnucleotide containing nucleic acid
#342Desmoglein 4 is a novel gene involved in hair growth
#343Antisense and antigene therapeutics with improved binding properties and methods for their use
#344Triplex hairpin ribozyme
#345Method and reagent for the treatment of diseases or conditions related to levels of vascular endothelial growth factor receptor
#346Polymearase III-based expression of therapeutic RNAs
#347Adeno-associated virus-delivered ribozyme compositions and methods for the treatment of retinal diseases
#348Compositions and methods for enhanced sensitivity and specificity of nucleic acid synthesis
#349RNA catalyst for cleaving specific RNA sequences
#350Conversion of non-neuronal cells into neurons